Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biosyntrx
Ophthalmic company announces new board member, start of new trial
May 14th, 2003
Biosyntrx announced that Stephen G. Slade, MD, a laser surgeon, renown for his clinical research, has joined the Biosyntrx Scientific Advisory Board and that the company has initiated a trial for a dry eye syndrome product. Slade will be one of the presenters at the event, which will also include Biosyntrx president and CMO Spencer Thornton, and Biosyntrx Scientific Advisory Board members Paul Arnold, MD, Richard Lindstrom, MD, Marguerite B. McDonald, MD, Robert H. Osher, MD, Priscilla Perry, MD, Noel Alpins, MD, and Hideharu Fukasaku, MD. "Slade is a renown ophthalmologist and surgeon, and we are pleased to have him on the team of leading physicians...
Source: Biotech Week (2003-05-14)
|
